These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 521251)

  • 21. [Insulin antibodies in untreated and insulin-treated diabetics].
    Ditsov S; Penchev I; Andreev D; Sirakov L; Turkolev N
    Vutr Boles; 1972; 11(3):95-9. PubMed ID: 4679989
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus.
    Bertrams J; Jansen FK; Grüneklee D; Reis HE; Drost H; Beyer J; Gries FA; Kuwert E
    Tissue Antigens; 1976 Jul; 8(1):13-9. PubMed ID: 960073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of antibodies on the activity and kinetics of administered insulin].
    Páv J; Srámková J
    Cas Lek Cesk; 1982 Oct; 121(41):1258-61. PubMed ID: 6756634
    [No Abstract]   [Full Text] [Related]  

  • 24. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
    Kurtz AB; Gray RS; Markanday S; Nabarro JD
    Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radioimmunological studies of anti-insulin antibodies in diabetes mellitus].
    Gligore V; Duma V; Boloşiu H; Simionescu L; Holan T; Derevenco V; Simon C
    Med Interna (Bucur); 1971 Apr; 23(4):431-6. PubMed ID: 5578653
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunogenicity of MC Lente Novo insulin].
    Rogala H; Lawecki J; Czyzyk A
    Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
    Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G
    Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical significance of insulin antibodies.
    Andersen OO; Egeberg J
    Acta Paediatr Scand Suppl; 1977; (270):63-8. PubMed ID: 278469
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin resistant diabetes mellitus.
    Zhu XX; Wang ZG; Qiu CL; Zhong XL
    Chin Med J (Engl); 1980 Nov; 93(11):737-44. PubMed ID: 6775883
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunobiological studies in two cases of insulin-resistant diabetes.
    de Assis LM; Nicolau W; Salomon JB; de Cintra AB; Pieroni RR
    AMB Rev Assoc Med Bras; 1970 Jan; 16(1):5-18. PubMed ID: 5311115
    [No Abstract]   [Full Text] [Related]  

  • 33. Experience with biosynthetic human insulin in diabetes.
    Kruger DF; Whitehouse FW; Kahkonen DM; Partamian JO; Fachnie JD; Goldman J; Leach D
    Henry Ford Hosp Med J; 1983; 31(2):72-6. PubMed ID: 6355014
    [No Abstract]   [Full Text] [Related]  

  • 34. [Monocomponet insulins].
    Rodríguez-Miñón JL
    Rev Clin Esp; 1978 Mar; 148(6):579-82. PubMed ID: 663334
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin binding capacity in patients changed from conventional to highly purified insulins. An indicator of likely response.
    Mustaffa BE; Daggett PR; Nabarro JD
    Diabetologia; 1977 Aug; 13(4):311-5. PubMed ID: 562300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of insulin-neutralizing antibodies using I-125-bound insulin].
    Láng I; Stützel M; Littmann L; Balázsi I
    Orv Hetil; 1974 Jan; 115(4):211-2. PubMed ID: 4839803
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant DNA insulins and diabetes mellitus. Short review and perspective.
    van der Veen EA; Heine RJ; van der Meer J
    Neth J Med; 1986; 29(2):62-4. PubMed ID: 3513036
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between HLA-B7 and allergic reactions to insulin in insulin-dependent diabetes mellitus.
    Bertrams J; Grüneklee D
    Tissue Antigens; 1977 Oct; 10(4):273-7. PubMed ID: 918938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for determination of anti-insulin antibodies in the plasma of insulin-treated diabetics.
    Sekso M; Resetić J; Riznar V; Solter M
    Acta Med Iugosl; 1978; 32(2):125-34. PubMed ID: 665291
    [No Abstract]   [Full Text] [Related]  

  • 40. [Presence of human insulin-binding antibodies in diabetes].
    Kosowicz J; Czekalski S; Faifrowski T
    Pol Arch Med Wewn; 1971 May; 46(5):591-8. PubMed ID: 5566932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.